RUS-350

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRUS-350
Drug Alias NameDihydrotetrabenazine isomer(+)-alpha-dihydrotetrabenazineRU-350RUS-350
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsSynaptic vesicular amine transporter inhibitors
TargetsSynaptic vesicular amine transporterSerotonin transporter
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlliance Pharm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlliance Pharm Pte. LtdBausch Health Companies Inc
Active IndicationsN/A
Inactive IndicationsHuntington Disease

Other Information

ATC CodeN/A
Related LinksN/A